Latest news with #Amdocs'
Economic Times
a day ago
- Business
- Economic Times
Amdocs layoffs 2025: Why this IT giant is cutting hundred of jobs?
Synopsis Amdocs is set to lay off hundreds of employees globally, including in Israel, as it strategically pivots towards artificial intelligence. The company has announced a new GenAI & Data division to integrate AI across its operations, marking a shift from previous layoffs driven by performance to a focus on technological transformation. Agencies Amdocs layoffs 2025 Israeli software and services company Amdocs is planning to lay off hundreds of employees worldwide as part of a strategic push toward artificial intelligence (AI). As per reports, the company announced a new GenAI & Data division, which will integrate AI across its previous workforce reductions, which were tied to performance or cost optimization, this latest round reflects a technological transformation aimed at embedding AI into Amdocs' core offerings. The GenAI & Data division will bring together engineering, strategy, product, and go-to-market teams under one structure. It is headed by Ilan Sade, Senior Vice President, and has been in development for two division is designed to enhance performance, accelerate innovation, and create added value for clients by embedding AI into the company's products and has not confirmed the exact number of job cuts, but reports suggest hundreds of employees globally, including in Israel, will be affected. The company has about 29,000 employees worldwide, with roughly 5,000 in Israel. This is the fourth major layoff at Amdocs in three years. In 2023, the company cut 2,700 jobs in two rounds, followed by 1,500 layoffs in 2024. Unlike earlier reductions, the current restructuring is driven by AI strategy rather than performance or move reflects a broader trend in the technology sector. Firms such as Microsoft and Intel have reduced headcounts while expanding AI investments. In the first seven months of 2025, tech companies worldwide eliminated over 89,000 jobs, with nearly half linked to AI-driven restructuring.
Time of India
a day ago
- Business
- Time of India
Amdocs layoffs 2025: Why this IT giant is cutting hundred of jobs?
Israeli software and services company Amdocs is planning to lay off hundreds of employees worldwide as part of a strategic push toward artificial intelligence (AI). As per reports, the company announced a new GenAI & Data division, which will integrate AI across its operations. Unlike previous workforce reductions, which were tied to performance or cost optimization, this latest round reflects a technological transformation aimed at embedding AI into Amdocs' core offerings. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program Amdocs GenAI & Data Division: A Strategic Shift The GenAI & Data division will bring together engineering, strategy, product, and go-to-market teams under one structure. It is headed by Ilan Sade, Senior Vice President, and has been in development for two years. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Tiger meeting her former zookeeper after 5 years. See what happens next! Story To Hear Undo The division is designed to enhance performance, accelerate innovation, and create added value for clients by embedding AI into the company's products and services. Layoffs: A Consequence of AI Transformation Amdocs has not confirmed the exact number of job cuts, but reports suggest hundreds of employees globally, including in Israel, will be affected. The company has about 29,000 employees worldwide, with roughly 5,000 in Israel. Live Events This is the fourth major layoff at Amdocs in three years. In 2023, the company cut 2,700 jobs in two rounds, followed by 1,500 layoffs in 2024. Unlike earlier reductions, the current restructuring is driven by AI strategy rather than performance or profitability. Amdocs' move reflects a broader trend in the technology sector. Firms such as Microsoft and Intel have reduced headcounts while expanding AI investments. In the first seven months of 2025, tech companies worldwide eliminated over 89,000 jobs, with nearly half linked to AI-driven restructuring.
Yahoo
13-05-2025
- Business
- Yahoo
Amdocs (NASDAQ:DOX) Has Announced A Dividend Of $0.527
Amdocs Limited (NASDAQ:DOX) will pay a dividend of $0.527 on the 25th of July. This makes the dividend yield about the same as the industry average at 2.3%. We check all companies for important risks. See what we found for Amdocs in our free report. While it is always good to see a solid dividend yield, we should also consider whether the payment is feasible. The last dividend was quite easily covered by Amdocs' earnings. This indicates that quite a large proportion of earnings is being invested back into the business. The next year is set to see EPS grow by 7.5%. Assuming the dividend continues along recent trends, we think the payout ratio could be 43% by next year, which is in a pretty sustainable range. View our latest analysis for Amdocs The company has a sustained record of paying dividends with very little fluctuation. The annual payment during the last 10 years was $0.62 in 2015, and the most recent fiscal year payment was $2.11. This implies that the company grew its distributions at a yearly rate of about 13% over that duration. Rapidly growing dividends for a long time is a very valuable feature for an income stock. Investors who have held shares in the company for the past few years will be happy with the dividend income they have received. Amdocs has seen EPS rising for the last five years, at 5.6% per annum. Earnings are on the uptrend, and it is only paying a small portion of those earnings to shareholders. In summary, it is always positive to see the dividend being increased, and we are particularly pleased with its overall sustainability. Earnings are easily covering distributions, and the company is generating plenty of cash. All of these factors considered, we think this has solid potential as a dividend stock. Investors generally tend to favour companies with a consistent, stable dividend policy as opposed to those operating an irregular one. However, there are other things to consider for investors when analysing stock performance. Companies that are growing earnings tend to be the best dividend stocks over the long term. See what the 5 analysts we track are forecasting for Amdocs for free with public analyst estimates for the company. Is Amdocs not quite the opportunity you were looking for? Why not check out our selection of top dividend stocks. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
07-05-2025
- Business
- Yahoo
A1 Bulgaria Successfully Completes Major Platform Upgrade with Amdocs to Improve Customer Experience
Convergent charging platform upgrade is the final stage in the Bulgarian operator's platform modernization program, providing end users with faster response times, greater billing transparency, and improved service reliability JERSEY CITY, NJ / ACCESS Newswire / May 7, 2025 / Amdocs (NASDAQ:DOX), a leading provider of software and services for communications and media companies, announced today that A1 Bulgaria has successfully completed a comprehensive modernization of its convergent charging platform, marking the culmination of A1 Bulgaria's platform modernization program, which includes Amdocs' flagship monetization and customer care solutions. With these solutions, A1 Bulgaria's end users can now enjoy smoother interactions, quicker resolutions, and real-time access to accurate account information, elevating their overall experience. The upgrade delivers performance improvements, including the ability to process millions of events per hour and handle thousands of transactions per second-both representing a leap in efficiency. Billing processing time has been reduced by more than half, and customer-facing interactions are now almost twice as fast, enhancing service quality and responsiveness. Additionally, backend API performance has improved significantly, while data synchronization times have been cut by over half. "We are at the forefront of digital transformation offering innovative services to answer the versatile digital needs of businesses and end-consumers alike," said Borislav Simeonov, Chief Technology Officer at A1 Bulgaria. "Therefore, Amdocs' expertise has been beneficial in achieving our ambitious goals. We've achieved a seamless upgrade that positions us to meet evolving market demands and better serve our customers with greater speed and reliability. We look forward to leveraging these advancements to continue leading the market." "Scalability, agility and flexibility are key to both continued growth and to meeting the rapidly evolving experience expectations of customers," said Anthony Goonetilleke, Group President of Technology and Head of Strategy at Amdocs. "We're proud to celebrate this milestone at A1 Bulgaria as they deliver seamless connected experiences to their customers." Supporting Resources Keep up with Amdocs news by visiting the company's website Follow us on X, Facebook, LinkedIn and YouTube About Amdocs Amdocs helps those who build the future to make it amazing. With our market-leading portfolio of software products and services, we unlock our customers' innovative potential, empowering them to provide next-generation communication and media experiences for both the individual end user and enterprise customers. Our employees around the globe are here to accelerate service providers' migration to the cloud, enable them to differentiate in the 5G era, and digitalize and automate their operations. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $5.00 billion in fiscal 2024. For more information, visit
Yahoo
08-04-2025
- Business
- Yahoo
Amdocs' (NASDAQ:DOX) earnings growth rate lags the 9.1% CAGR delivered to shareholders
Amdocs Limited (NASDAQ:DOX) shareholders might be concerned after seeing the share price drop 10% in the last week. But the silver lining is the stock is up over five years. In that time, it is up 40%, which isn't bad, but is below the market return of 94%. While this past week has detracted from the company's five-year return, let's look at the recent trends of the underlying business and see if the gains have been in alignment. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. During five years of share price growth, Amdocs achieved compound earnings per share (EPS) growth of 4.1% per year. This EPS growth is slower than the share price growth of 7% per year, over the same period. So it's fair to assume the market has a higher opinion of the business than it did five years ago. That's not necessarily surprising considering the five-year track record of earnings growth. The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image). It might be well worthwhile taking a look at our free report on Amdocs' earnings, revenue and cash flow . It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. In the case of Amdocs, it has a TSR of 55% for the last 5 years. That exceeds its share price return that we previously mentioned. And there's no prize for guessing that the dividend payments largely explain the divergence! We regret to report that Amdocs shareholders are down 3.8% for the year (even including dividends). Unfortunately, that's worse than the broader market decline of 2.4%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Longer term investors wouldn't be so upset, since they would have made 9%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. Is Amdocs cheap compared to other companies? These 3 valuation measures might help you decide. We will like Amdocs better if we see some big insider buys. While we wait, check out this free list of undervalued stocks (mostly small caps) with considerable, recent, insider buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
